Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.42 AUD | +3.65% | +10.94% | +20.34% |
04-16 | XRF Scientific's Profit Before Tax Rises 15% in March Quarter | MT |
02-20 | XRF Scientific Shares Decline 5% Despite Higher Fiscal H1 Revenue, EPS | MT |
Sales 2024 * | 59.1M 38.8M 3.1B | Sales 2025 * | 63.8M 41.88M 3.34B | Capitalization | 189M 124M 9.92B |
---|---|---|---|---|---|
Net income 2024 * | 8M 5.25M 419M | Net income 2025 * | 10M 6.56M 524M | EV / Sales 2024 * | 3.02 x |
Net cash position 2024 * | 10.9M 7.16M 571M | Net cash position 2025 * | 15.4M 10.11M 807M | EV / Sales 2025 * | 2.72 x |
P/E ratio 2024 * |
21.1
x | P/E ratio 2025 * |
18.8
x | Employees | 48 |
Yield 2024 * |
2.26% | Yield 2025 * |
2.55% | Free-Float | 63.69% |
1 day | +3.65% | ||
1 week | +10.94% | ||
Current month | +15.45% | ||
1 month | +17.36% | ||
3 months | +32.71% | ||
6 months | +48.69% | ||
Current year | +20.34% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 31/05/08 | |
Andrew Watson
DFI | Director of Finance/CFO | - | 27/08/13 |
Members of the board | Title | Age | Since |
---|---|---|---|
Fred Grimwade
CHM | Chairman | 66 | 30/04/12 |
David Kiggins
BRD | Director/Board Member | 54 | 30/04/12 |
David Brown
BRD | Director/Board Member | 86 | 06/06/04 |
Date | Price | Change | Volume |
---|---|---|---|
29/04/24 | 1.42 | +3.65% | 260 926 |
26/04/24 | 1.37 | +3.40% | 313,897 |
24/04/24 | 1.325 | +4.74% | 238,851 |
23/04/24 | 1.265 | -1.17% | 142,151 |
22/04/24 | 1.28 | +0.79% | 119,983 |
Delayed Quote Australian S.E., April 29, 2024 at 03:46 am
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.34% | 123M | |
+16.41% | 26.44B | |
+23.59% | 5.15B | |
+24.24% | 4.54B | |
+25.80% | 1.63B | |
-16.19% | 1.08B | |
+8.01% | 1.06B | |
-35.45% | 910M | |
-6.14% | 734M | |
+2.55% | 447M |
- Stock Market
- Equities
- XRF Stock